胸腺五肽结构式
|
常用名 | 胸腺五肽 | 英文名 | Thymopentin |
---|---|---|---|---|
CAS号 | 69558-55-0 | 分子量 | 679.765 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | N/A | |
分子式 | C30H49N9O9 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | N/A |
胸腺五肽用途Thymopentin 是一种主要由胸腺皮质和髓质上皮细胞分泌的生物活性肽。Thymopentin 是一种有效的免疫调节剂,具有很短的血浆半衰期 (30 秒)。Thymopentin 能促使自人类胚胎干细胞产生 T 细胞群。 |
中文名 | 胸腺五肽 |
---|---|
英文名 | Thymopentin |
中文别名 | 胸腺生成素 | 刹莫潘汀 |
英文别名 | 更多 |
描述 | Thymopentin 是一种主要由胸腺皮质和髓质上皮细胞分泌的生物活性肽。Thymopentin 是一种有效的免疫调节剂,具有很短的血浆半衰期 (30 秒)。Thymopentin 能促使自人类胚胎干细胞产生 T 细胞群。 |
---|---|
相关类别 | |
体外研究 | 胸腺五肽在体外增强来自hESC的T细胞谱系的产生[1]。 |
参考文献 |
密度 | 1.4±0.1 g/cm3 |
---|---|
分子式 | C30H49N9O9 |
分子量 | 679.765 |
精确质量 | 679.365295 |
PSA | 325.17000 |
LogP | -0.89 |
折射率 | 1.636 |
储存条件 | −20°C |
稳定性 | 本品是合成的腓肠胸腺多肽(thymopoietin)的衍生物,可引起选择性T细胞分化,所以是细胞结合免疫反应的缘由。虽然它仅有五肽,对免疫系统具有相同性质。 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) | Xi |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
Int. J. Pharm. 427(2) , 385-92, (2012) The objective of this study was to investigate the stability and aerosolization of pressurized metered dose inhalers (pMDIs) containing thymopentin nanoparticles. Thymopentin nanoparticles, fabricated... |
|
Separation and purification of thymopentin with molecular imprinting membrane by solid phase extraction disks.
J. Pharm. Biomed. Anal. 102 , 137-43, (2014) The synthesis and performance of molecularly imprinted membranes (MIMs) as a solid phase extraction packing materials for the separation and purification of thymopentin from crude samples was describe... |
|
[Vulvar lesions caused by Papillomavirus (HPV): effectiveness of thymopentin (Syntomoduline). First results and experiences].
Minerva Ginecol. 43(1-2) , 53-6, (1991) The study included two different sized groups of patients suffering from various degrees of valvular microcondylomatosis. A group of 40 patients was treated using combined therapy while a second group... |
L-Tyrosine, N-(N-(N-(N2-L-arginyl-L-lysyl)-L-α-aspartyl)-L-valyl)- |
TP-5 |
RKDVY |
THYMOPENTIN 5 |
Thymopentin |
Arg-Lys-Asp-Val-Tyr |
thymopoietin |
MFCD00214200 |
N-[N-[N-(N2-L-Arginyl-L-lysyl)-L-a-aspartyl]-L-valyl]-L-tyrosine |
THYMOPETIN |
L-Arginyl-L-lysyl-L-α-aspartyl-L-valyl-L-tyrosine |
L-Tyrosine, L-arginyl-L-lysyl-L-α-aspartyl-L-valyl- |
thymopoietin fragment 32-36 |
Timunox |
HArgLysAspValTyrOH |
Immunox |
N-(diaminomethylidene)-L-ornithyl-L-lysyl-L-α-aspartyl-L-valyl-L-tyrosine |
Thymopoietin 32-36 |
THYMOPOIETIN PENTAPEPTIDE |
Sintomodulina |